DOMINIQUE BENJAMIN: Open Payments
NPI 1790220879 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 41 payments from 10 companies in 2025. Trend: 2023 $267 · 2024 $561 · 2025 $942
Food & beverage: $857Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $337 |
| GENZYME CORPORATION | 7 | $187 |
| Arcutis Biotherapeutics, Inc. | 4 | $87 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Janssen Biotech, Inc. | 2 | $61 |
| UCB, Inc. | 1 | $45 |
| Organon LLC | 3 | $31 |
| Amgen Inc. | 1 | $28 |
| Incyte Corporation | 1 | $18 |
Products named: BOTOX, DUPIXENT, Zoryve, SKYRIZI, COSENTYX, TREMFYA, Bimzelx, VTAMA.
Industry payments across CA — which companies pay providers there.
